NYSE:HAEMedical Equipment
Can New VASCADE MVP XL Data Strengthen Haemonetics' (HAE) Moat in Electrophysiology Adjacent Markets?
Haemonetics Corporation recently reported publication of a large Emory University retrospective study of 1,623 patients, showing its VASCADE MVP XL venous vascular closure system achieved rapid hemostasis, high same-day discharge rates and a low rate of vascular complications in large-bore sheath electrophysiology procedures following earlier FDA label expansion.
The findings add real-world backing to VASCADE MVP XL as the only extravascular venous closure system clinically proven in...